PCN5 TREATMENT EFFECT OF RITUXIMAB, FLUDARABINE AND CYCLOPHOSPHAMIDE (R-FC) VERSUS FC IN CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL) IN AN OBSERVATIONAL SETTING- AN INVESTIGATION OF PROGNOSTIC FACTORS AND LIFETIME HEALTH OUTCOMES
Nov 1, 2008, 00:00
10.1016/S1098-3015(10)66543-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)66543-6/fulltext
Title :
PCN5 TREATMENT EFFECT OF RITUXIMAB, FLUDARABINE AND CYCLOPHOSPHAMIDE (R-FC) VERSUS FC IN CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL) IN AN OBSERVATIONAL SETTING- AN INVESTIGATION OF PROGNOSTIC FACTORS AND LIFETIME HEALTH OUTCOMES
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66543-6&doi=10.1016/S1098-3015(10)66543-6
First page :
Section Title :
Open access? :
No
Section Order :
378